Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease

Mol Ther. 2023 Jul 5;31(7):2296. doi: 10.1016/j.ymthe.2023.04.009. Epub 2023 Apr 24.

Authors

Matthew T Rocco, Asad S Akhter, Debra J Ehrlich, Gretchen C Scott, Codrin Lungu, Vikas Munjal, Anthony Aquino, Russell R Lonser, Massimo S Fiandaca, Mark Hallett, John D Heiss, Krystof S Bankiewicz

PMID: 37098347
PMCID: PMC10362408 (available on 2024-07-05)
DOI: 10.1016/j.ymthe.2023.04.009

No abstract available

Publication types

Published Erratum